Barclays PLC Acquires 100,678 Shares of Neumora Therapeutics, …

1 day ago  · Barclays PLC raised its stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) by 352.9% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 129,210 ...


Install CouponFollow Chrome Extension   CouponFollow Extension

9%
OFF

Barclays PLC Acquires 100,678 Shares Of Neumora Therapeutics, …

1 day from now

1 day ago  · Barclays PLC raised its stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) by 352.9% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 129,210 ...

etfdailynews.com

9%
OFF

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Acquired

1 day from now

1 day ago  · Barclays PLC raised its stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) by 352.9% in the 3rd quarter, according to its most recent filing with the SEC. The …

marketbeat.com

$10.39
OFF

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Stake Trimmed By …

1 day from now

Dec 11, 2024  · Neumora Therapeutics Price Performance. Shares of Neumora Therapeutics stock opened at $10.39 on Wednesday. The firm has a market cap of $1.68 billion, a price-to …

etfdailynews.com

$10.63
OFF

Traders Purchase Large Volume Of Put Options On Neumora …

1 day from now

4 days ago  · Shares of NASDAQ NMRA opened at $10.63 on Wednesday. Neumora Therapeutics has a 1 year low of $8.33 and a 1 year high of $21.00. The firm’s 50-day moving …

etfdailynews.com

03%
OFF

This Is What Whales Are Betting On Neumora Therapeutics

1 day from now

2 days ago  · Neumora Therapeutics's Current Market Status Currently trading with a volume of 422,366, the NMRA's price is up by 1.03%, now at $10.74. RSI readings suggest the stock is …

nasdaq.com

$166000
OFF

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Purchased

1 day from now

Dec 7, 2024  · Principal Financial Group Inc. bought a new stake in shares of Neumora Therapeutics during the second quarter valued at approximately $166,000. Finally, Intech …

marketbeat.com

$86621
OFF

Kreg Therapeutics, Inc. Careers In North Bergen, NJ

1 day from now

Kreg Therapeutics, Inc. salaries in North Bergen, NJ. Salary estimated from 23 employees, users, and past and present job advertisements on Indeed. Clinic Manager. $86,621 per year. …

indeed.com

$1200
OFF

Rooms For Rent In Bergen County, NJ | SpareRoom

1 day from now

1 room Palisades Park (07650) $1,200/month Utilities inc. | No Fee Palisades Park private house of Korean family, super convenient location/only 5 minute walk to Broad Ave & Columbia Ave …

spareroom.com

2%
OFF

Neumora Therapeutics (NASDAQ:NMRA) Shares Up 7.2% - Here's …

1 day from now

2 days ago  · Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report)'s share price was up 7.2% on Thursday . The stock traded as high as $11.43 and last traded at $11.40. …

marketbeat.com

3%
OFF

Neumora Therapeutics (NASDAQ:NMRA) Shares Down 3

1 day from now

4 days ago  · Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) dropped 3% during mid-day trading on Tuesday . The stock traded as low as $10.58 and last traded at …

marketbeat.com

FAQs about Barclays PLC Acquires 100,678 Shares of Neumora Therapeutics, … Coupon?

Does manufacturers life insurance own neumora Therapeutics (NMRA)?

The Manufacturers Life Insurance Company lowered its stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) by 1.8% during the third quarter, HoldingsChannel reports. The firm owned 109,802 shares of the company’s stock after selling 2,026 shares during the period. ...

Who owns neumora Therapeutics?

Ballentine Partners LLC acquired a new stake in Neumora Therapeutics during the 3rd quarter worth about $178,000. Finally, SkyOak Wealth LLC acquired a new stake in Neumora Therapeutics during the 2nd quarter worth about $147,000. Hedge funds and other institutional investors own 47.65% of the company’s stock. ...

How much did neumora Therapeutics (NMRA) earn in a quarter?

Neumora Therapeutics (NASDAQ:NMRA – Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.06). During the same quarter in the previous year, the company earned ($1.14) EPS. ...

Does Amalgamated Bank own neumora Therapeutics?

Amalgamated Bank increased its stake in Neumora Therapeutics by 472.8% in the 2nd quarter. Amalgamated Bank now owns 2,910 shares of the company’s stock worth $29,000 after purchasing an additional 2,402 shares in the last quarter. Quarry LP acquired a new stake in Neumora Therapeutics during the 2nd quarter worth about $98,000. ...

Is neumora Therapeutics a good stock to buy?

JPMorgan Chase & Co. downgraded shares of Neumora Therapeutics from an “overweight” rating to a “neutral” rating and reduced their price target for the stock from $18.00 to $15.00 in a research report on Tuesday, November 5th. ...

When did neumora Therapeutics IPO?

Neumora Therapeutics (NMRA) raised $250 million in an IPO on Friday, September 15th 2023. The company issued 14,710,000 shares at $17.00 per share. Who are Neumora Therapeutics' major shareholders? ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension